Levels of total tau and tau protein phosphorylated at threonine 181 in patients with incipient and manifest Alzheimer's disease

Neuroscience Letters

Volumn 339, Issue 2, 2003, Pages 172-174

  Schönknecht, Peter ^a   Pantel, Johannes ^a   Hunt, Aoife ^a   Volkmann, Martin ^a   Buerger, Katharina ^b   Hampel, Harald ^b   Schröder, Johannes ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Alzheimer's disease; Tau protein; Threonine 181

Indexed keywords

TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; DEVICE; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; MALE; MEDICAL EXAMINATION; MULTIINFARCT DEMENTIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN PHOSPHORYLATION;

EID: 0037457355     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(02)01481-7     Document Type: Article

References (13)

1. Andreasen N., Minthon L., Clarberg A., Davidsson P., Gottfries J., Vanmechelen E., Vanderstichele H., Winblad B., Blennow K. Sensitivity, specificity, and stability of CSF-tau in AD in a community based patient sample. Neurology. 53:1999;1488-1494.
2. Arai H., Ishiguro K., Ohno H., Moriyama M., Itoh N., Okamura N., Matsui T., Morikawa Y., Horikawa E., Kohno H., Sasaki H., Imahori K. CSF phosphorylated tau protein and mild cognitive impairment: a prospective study. Exp. Neurol. 166:2000;201-203.
3. Blennow K., Vanmechelen E., Hampel H. CSF total tau, Aβ42 and phosphorylated tau protein as biomarkers for Alzheimer's disease. Mol. Neurobiol. 24:2001;87-97.
4. Buerger K., Teipel S., Zinkowski R., Blennow K., Arai H., Engel R., Hofmann-Kiefer K., McCulloch B.S., Ptok U., Heun R., Andreasen N., DeBernardis J., Kerkmann D., Moeller H.-J., Davies P., Hampel H. CSF tau protein phosphorylated at threonine 231 correlates with cognitive decline in MCI subjects. Neurology. 59:2002;627-629.
5. Buerger K., Zinkowski R., Teipel S., Tapiola T., Arai H., Blennow K., Andreasen N., Hofmann-Kiefer K., DeBernardis J., Kerkmann D., McCulloch C., Kohnken R., Padberg F., Pirttilä T., Schapiro M., Rapoport S., Möller H.-J., Davies P., Hampel H. Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231. Arch. Neurol. 59:2002;1267-1272.
6. Hampel H., Buerger K., Kohnken R., Teipel S., Zinkowski R., Moeller H.-J., Rapoport S.I., Davies P. Tracking of Alzheimer's disease progression with cerebrospinal fluid tau protein phosphorylated at threonine 231. Ann. Neurol. 49:2001;545-546.
7. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 34:1984;939-965.
8. Parnetti L., Lanari A., Amici S., Gallai V., Vanmechelen E., Hulstaert F. CSF phosphorylated tau is a possible marker for discriminating Alzheimer's disease from dementia with Lewy bodies. Neurol. Sci. 22:2001;77-78.
9. Roman G.C., Tatemichi T.K., Erkinjuntti T., Cummings J.L., Masdeu J.C., Garcia J.H., Amaducci L., Orgogozo J.M., Brun A., Hofman A. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology. 43:1993;250-260.
10. Schönknecht P., Pantel J., Hartmann T., Werle E., Volkmann M., Essig M., Amann M., Zanabili N., Bardenheuer H., Hunt A., Schröder J. Cerebrospinal fluid tau levels in Alzheimer's disease are elevated when compared to vascular dementia but do not correlate with measures of cerebral atrophy. Psychiat. Res. 2003;. in press.
11. Sjögren M., Vanderstichele H., Agren H., Zachrisson O., Edsbagge M., Wikkelso C., Skoog I., Wallin A., Wahlund L.O., Marcusson J., Nägga K., Andreasen N., Davidsson P., Vanmechelen E., Blennow K. Tau and Aβ42 in cerebrospinal fluid from healthy adults 21-93 years of age: establishment of reference values. Clin. Chem. 47:2001;1776-1781.
12. Skoog I., Vanmechelen E., Andreasson L.A., Palmertz B., Davidsson P., Hesse C., Blennow K. A population-based study of tau protein and ubiquitin in cerebrospinal fluid in 85-year-olds: relation to severity of dementia and cerebral atrophy, but not to the apolipoprotein E4 allele. Neurodegeneration. 4:1995;433-442.
13. Vanmechelen E., Vanderstichele H., Davidsson P., Van Kerschaver E., Van Der Perre B., Sjogren M., Andreasen N., Blennow K. Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization. Neurosci. Lett. 285:2000;49-52.